上海瀚鸿化工科技有限公司
中国 |
|
| | |
|
| PT-141 |
(产品照片) |
| | PT-141 is Palatin’s novel drug candidate for the treatment of male and female sexual dysfunction. First in a new class of therapies called melanocortin agonists, PT-141 has shown promise in effectively treating erectile dysfunction (ED) without the cardiovascular effects found in ED drugs currently available. PT-141 works through a mechanism of action involving the central nervous system rather than directly on the vascular system. As a result, it may offer significant safety and efficacy benefits over currently available products. To date, PT-141 has shown positive results in four Phase 2 efficacy studies enrolling more than 300 men. Palatin has also conducted a Phase 1 study in 32 premenopausal women without sexual dysfunction, in which the drug was shown to be safe and well tolerated. A Phase 2A pilot clinical study evaluating PT-141 in pre-menopausal women diagnosed with female sexual dysfunction (FSD) has shown encouraging results | | |
|
| 地区: | 中国 |
| 付款方法: | 西部联盟 |
| 数量: | 100mg |
| 包装 & 交货: | 10mg/vial |
你的询问将被记录在"会员商业电邮"。 |
推荐给你的朋友的贸易 |
|
|
)
